Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs MSTZ✓SelectedUSD · MSTZGSK vs MSTZ performance historyLatest closeAs of-1.56%11/19
Stock and ETF performance explorer

GSK vs MSTZ

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+23.1%
MSTZ return
-98.6%
Excess return
+121.8%
Maximum drawdown
-23.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMSTZExcessAlpha
1D-1.6%+9.5%-11.0%-1.6%
7D-4.7%+68.4%-73.1%-5.1%
30D-4.7%+135.2%-139.9%-5.4%
3M-8.8%-22.2%+13.5%-8.9%
6M-4.6%+19.2%-23.9%-5.5%
YTD+1.0%-60.2%+61.2%+0.5%
1Y+6.9%-45.8%+52.7%+5.8%
All+23.1%-98.6%+121.8%+21.9%

Cumulative growth

Daily Returns

Daily percentage return beside MSTZ.

Daily Out/Under-Performance

Portfolio return minus MSTZ return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MSTZ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MSTZ wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling